$5.45
-0.24-4.22%
At close: -
$5.45
0.000.00%
After Hours: Jan 24, 4:02 PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Acrivon Therapeutics in recent months.
Browse guidance and forecast on all stocks.